Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Portage Biotech
Biotech
Portage launches Tarus' solid tumor portfolio into new offshoot
Over 2 years after acquiring Tarus, Portage is launching Tarus’ adenosine receptor antagonists in a standalone company helmed by a familiar leader
James Waldron
Jan 6, 2025 10:00am
Portage finds hope in sale of iNKT agonists to Immunova
Dec 17, 2024 8:15am
AI firm Xaira powers up C-suite with pharma vet—Chutes & Ladders
Dec 13, 2024 8:30am
Portage Biotech hints at potential closure as it halts programs
Apr 12, 2024 10:22am
